Scholarlink

<p><i>Klebsiella pneumoniae</i> is a major cause of bloodstream infections worldwide and is increasingly associated with multidrug resistance, particularly to carbapenems and colistin, which severely limits treatment options. This study investigated the genomic epidemiology of <i>K. pneumoniae</i> bloodstream infection (BSI) isolates collected in Thailand between 2020 and 2024. A total of 227 <i>K. pneumoniae</i> BSI isolates collected nationwide through the National Antimicrobial Resistance Surveillance Center, Thailand were subjected to antimicrobial susceptibility testing and whole-genome sequencing, followed by multilocus sequence typing, AMR gene detection, plasmid profiling, virulence scoring, phylogenetic analysis, and genotype–phenotype correlation. Among the isolates, 199 were resistant to carbapenems, seven were resistant only to colistin, and 21 were not resistant to either carbapenems or colistin. Three high-risk sequence types (ST) (ST16, ST147, and ST231) predominated in most regions, whereas the south showed greater clonal diversity. ST16 isolates commonly co-harbored <i>bla</i><sub>NDM−1</sub> and <i>bla</i><sub>OXA−232</sub> and had high rates of carbapenem and colistin co-resistance. ST231 isolates exhibited carbapenem resistance along with <i>rmtF1</i>-mediated aminoglycoside resistance, whereas ST147 isolates demonstrated high genomic plasticity and resistance diversity. Rare ST isolates carrying <i>mcr</i> genes and hypervirulent ST23 and ST268 lineages were also identified, with ST268 resistant to all carbapenems tested. These findings highlight the dissemination of high-risk clones in Thailand and underscore the need for real-time genomic surveillance and molecular diagnostics to inform infection control and national AMR strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nationwide genomic surveillance of carbapenem- and colistin-resistant Klebsiella pneumoniae bloodstream isolates in Thailand (2020–2024)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月20日

查看全文
  • Kulsumpun Krobanan,
  • Watcharaporn Kamjumphol,
  • Phimrata Leethongdee,
  • Aekkawat Unahalekhaka,
  • Orapan Sripichai,
  • Nattapong Cheunban,
  • Nalumon Thadtapong,
  • Chattip Kurehong,
  • Pilailuk Akkapaiboon Okada,
  • Jiraphan Premsuriya

摘要

Klebsiella pneumoniae is a major cause of bloodstream infections worldwide and is increasingly associated with multidrug resistance, particularly to carbapenems and colistin, which severely limits treatment options. This study investigated the genomic epidemiology of K. pneumoniae bloodstream infection (BSI) isolates collected in Thailand between 2020 and 2024. A total of 227 K. pneumoniae BSI isolates collected nationwide through the National Antimicrobial Resistance Surveillance Center, Thailand were subjected to antimicrobial susceptibility testing and whole-genome sequencing, followed by multilocus sequence typing, AMR gene detection, plasmid profiling, virulence scoring, phylogenetic analysis, and genotype–phenotype correlation. Among the isolates, 199 were resistant to carbapenems, seven were resistant only to colistin, and 21 were not resistant to either carbapenems or colistin. Three high-risk sequence types (ST) (ST16, ST147, and ST231) predominated in most regions, whereas the south showed greater clonal diversity. ST16 isolates commonly co-harbored blaNDM−1 and blaOXA−232 and had high rates of carbapenem and colistin co-resistance. ST231 isolates exhibited carbapenem resistance along with rmtF1-mediated aminoglycoside resistance, whereas ST147 isolates demonstrated high genomic plasticity and resistance diversity. Rare ST isolates carrying mcr genes and hypervirulent ST23 and ST268 lineages were also identified, with ST268 resistant to all carbapenems tested. These findings highlight the dissemination of high-risk clones in Thailand and underscore the need for real-time genomic surveillance and molecular diagnostics to inform infection control and national AMR strategies.